Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tafuri A, Bondi D, Princiotta A, Pietrangelo T, Yadav P, Altieri VM, et al
A 36-year-old man with history of anxiety, obsessive compulsive disorder (OCD), and tic disorder (on treatment with sodium valproate 300 mg for the past 6 months, risperidone 2 mg/day for 2 years, and haloperidol for the last 3 days) was referred to us after becoming drowsy and unresponsive over the previous 2 days following disproportionate drowsiness after administration of haloperidol and promethazine for acute aggressive behavior, retching, and vomiting
LWT-Food Science and Technology , 142, 110881
Leading companies continue to focus on developing new and improved molecules with shorter dosing frequency and improved safety and tolerability, reducing the performance gap with injectable medications
doi:10.1111/dom.13172
It offers no therapeutic benefit
US$ 22.39
US$ 22.06
US$ 24.71
US$ 23.03
US$ 22.43
US$ 28.56
US$ 27.12
US$ 24.78
US$ 27.16
US$ 22.35
